Proxy Statement

Phio Pharmaceuticals Corp. Filed 2022-11-30 Acc 0001683168-22-008106

Documents 1

2023-06-09 DEF 14A Proxy Statement
2022-12-05 4 Director bought 5,000 shares at $0.41 ($2,041)
2022-12-02 DEFA14A Proxy Materials
2022-11-30 DEF 14A Proxy Statement
2022-11-29 4 Interim Executive Chairman bought 2,715 shares at an average $0.42 ($1,136)
2022-11-28 4 Director bought 2,000 shares at $0.41 ($820)
2022-06-30 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading phio_def14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…